Morbidity and mortality | Vancomycin | Linezolid | P value |
Expired Transferred to ward Discharged | 4 (19.0%) 6 (28.6%) 11 (52.4%) | 1 (5.3%) 5 (26.3%) 13 (68.4%) | 0.375
|
Resolution/improvement of fever | 12 (57.1%) | 12 (63.2%) | 0.698 |
Resolution/improvement of leukocytosis | 15 (71.4%) | 14 (73.7%) | 0.873 |
Resolution/improvement of purulent sputum | 6 (28.6%) | 4 (21.1%) | 0.429 |
Resolution/improvement of dyspnea | 8 (38.1%) | 3 (15.8%) | 0.115 |
Resolution/improvement of cough | 4 (19.0%) | 4 (21.1%) | 0.592 |
Microbiological eradication of MRSA from sputum culture | 2 (9.5%) | 6 (31.6%) | 0.089 |
Improvement or lack of progression of radiographic finding (pulmonary infiltration) | 17 (81.0%) | 16 (84.2%) | 0.559 |